These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3072214)

  • 21. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated.
    Koevary SB
    Diabetes Res; 1990 Mar; 13(3):133-8. PubMed ID: 2091881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.
    Nagata M; Yokono K; Hayakawa M; Kawase Y; Hatamori N; Ogawa W; Yonezawa K; Shii K; Baba S
    J Immunol; 1989 Aug; 143(4):1155-62. PubMed ID: 2663991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia.
    Peters WH; Lester FT; Kohnert KD; Hildmann W
    Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phagocytic activity of blood cells in diabetic risk probands and newly diagnosed type 1 diabetics.
    Köhler E; Bock U; Knospe S; Michaelis D; Rjasanowski I
    Exp Clin Endocrinol; 1988 Aug; 91(3):259-64. PubMed ID: 3251767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
    Sobel DO; Creswell K
    Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk.
    Rjasanowski I; Michaelis D; Dietz H; Witt S; Köhler E; Knospe S
    Exp Clin Endocrinol; 1985 Feb; 85(1):70-4. PubMed ID: 3886413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models.
    Charles MA; Suzuki M; Slater L; Waldeck N; Ong K
    Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defect of cellular suppressor function in the pathogenesis of type I diabetes mellitus.
    Lohmann D; Lampeter E; Krug J; Bierwolf B; Verlohren HJ
    Exp Clin Endocrinol; 1987 Aug; 89(3):340-4. PubMed ID: 2959493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does protease inhibitor inhibit complement activation caused by the immune complex associated with islet cell surface antibody?
    Okada S; Sato K; Ichiki K; Tanokuchi S; Ishii K; Ota Z; Takeda A
    J Int Med Res; 1991; 19(3):234-6. PubMed ID: 1936512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum C3 and C4 levels and complement-dependent antibody-mediated cytotoxic activity of islet cell surface antibody in type 1 (insulin-dependent) diabetic children.
    Okada S; Sato K; Miyai Y; Masaki Y; Higuchi T; Ogino Y; Ota Z
    Diabetologia; 1987 Nov; 30(11):869-73. PubMed ID: 3328722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immune reactions against B cells and defect of suppressor cell activity in type 1 (insulin-dependent) diabetes mellitus.
    Lohmann D; Krug J; Lampeter EF; Bierwolf B; Verlohren HJ
    Diabetologia; 1986 Jul; 29(7):421-5. PubMed ID: 2943624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-beta-cell immunity in insulinopenic diabetic dogs.
    Sai P; Debray-Sachs M; Jondet A; Gepts W; Assan R
    Diabetes; 1984 Feb; 33(2):135-40. PubMed ID: 6363167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytes from diabetics suppress insulin release in vitro.
    Boitard C; Debray-Sachs M; Pouplard A; Assan R; Hamburger J
    Diabetologia; 1981 Jul; 21(1):41-6. PubMed ID: 7024027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible toxic effects of normal and diabetic patient serum on pancreatic B-cells.
    Lernmark A; Sehlin J; Täljedal IB; Kromann H; Nerup J
    Diabetologia; 1978 Jan; 14(1):25-31. PubMed ID: 342324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus.
    Eisenbarth GS; Morris MA; Scearce RM
    J Clin Invest; 1981 Feb; 67(2):403-8. PubMed ID: 7007435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.